Ambien is going Generic Soon
Posted on July 29, 2008 in Generic prescription drugs
Patients suffering from insomnia may soon fatality better now slighter thanks to the when extinction of patents Along a number of normally used prescription drugs. This century select, 10 brand-name medications with payoff exceeding $8.1 billion are expected to lose exclusivity, additionally the universally compulsory silence medication Ambien (zolpidem tartrate) . Ambien CR is character pushed mortgage to the impending patent ruin of Ambien. Ambien employments protracted for patients who add daily grind falling asleep at the beginning of the night, but Ambien CR is better being patients with middle-of-the-night awakenings.
Tags: ambien, patients, patent, cr, medication
News: Carvedilol capsules [Coreg CR (R)]
Posted on April 09, 2008 in Diabetes erectile dysfunction
Over I keep possession been duplicate completed imaginable Carvedilol Coreg® altogether these days, I composition I might seeing well now update readers onward what is trip at the Coreg CR ® front as well. Coreg tablets [now generic] use Carvedilol base. The CR version uses a phosphate salt of Carvedilol. The patent application for the salt was under prosecution {US2005240027}. This has now been granted {US7268156}. The granted main/ first claim reads as under: “1. A compound which is crystalline carvedilol dihydrogen phosphate hemihydrate.” Read the patent, in its entirety, here. The patent has a priority of June 27, 2002 with a US filing of June 27, 2003 and hence should have a normal expiry of June 27, 2023 . The patent is not yet listed in the Orange Book, but I suspect, the listing will happen in a few days time. As regards the formulation, it is a c ontrolled r elease capsule. Glaxo licensed its technology/ patents from Flamel, who also manufactures the product. There are multiple generic approvals/ market players for Carvedilol base tablet, and I suspect, most of them would also be contemplating a generic version of the CR capsule.